Werum worldwide
 Home  Company News & Events Jobs & Career   Contact     Search  
Genzyme's prescription for success


Summary

In 2001 Genzyme, a market-leading biotechnology company headquartered in Boston, USA, decided to establish a manufacturing site in Ireland to complete 'tabletting' operations for the manufacture of Renagel, which is a polymer product used to treat dialysis patients. In the course of enhancements Genzyme has finished the installation of latest technology, including automatic goods vehicles and totally automated manufacturing processes. Also on board: Werum's PAS-X.

The article describes the premises and the transformation of the site into a state-of-the-art manufacturing facility which sets new standards of excellence in quality, compliance and efficiency.

This article has been released in Manufacturing Today, November/December 2006.


For downloading the pdf file please register in the download screen. All information you provide to us will be kept strictly confidential, and it will not be shared with third parties. The data shall be used for internal purposes only. For further details please refer to our Privacy statement.

Format: pdf
Filesize: 850 KB




© Werum Software & Systems AG 2012 Privacy Statement Sitemap Print Page